0000899243-22-020487.txt : 20220601 0000899243-22-020487.hdr.sgml : 20220601 20220601173441 ACCESSION NUMBER: 0000899243-22-020487 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220527 FILED AS OF DATE: 20220601 DATE AS OF CHANGE: 20220601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Iskra Michael S. CENTRAL INDEX KEY: 0001839432 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41409 FILM NUMBER: 22988480 MAIL ADDRESS: STREET 1: C/O ORTHO CLINICAL DIAGNOSTICS HOLDINGS STREET 2: 1001 ROUTE 202 CITY: RARITAN STATE: NJ ZIP: 08869 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QuidelOrtho Corp CENTRAL INDEX KEY: 0001906324 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 552-1100 MAIL ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Coronado Topco, Inc. DATE OF NAME CHANGE: 20220124 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-27 0 0001906324 QuidelOrtho Corp QDEL 0001839432 Iskra Michael S. 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 0 1 0 0 Chief Commercial Officer Stock Options 59.53 2022-05-27 4 A 0 22020 0.00 A 2025-12-21 Common Stock 22020 22020 D Stock Options 119.06 2022-05-27 4 A 0 16809 0.00 A 2024-05-27 Common Stock 16809 16809 D Restricted Stock Units 2022-05-27 4 A 0 15825 0.00 A Common Stock 15825 15825 D Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each Ortho stock option was converted into a Stock Option to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions), except as adjusted by the Business Combination Agreement. Vested in full. 9,804 shares are vested in full; 7,005 shares will vest on July 1, 2022. Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. Pursuant to the Business Combination Agreement, each Ortho restricted stock unit was converted into a restricted stock unit representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions), except as adjusted by the Business Combination Agreement. 15,825 shares will vest on April 1, 2023. /s/ Phillip S. Askim, attorney-in-fact for Michael S. Iskra 2022-06-01